Reata Pharmaceuticals: Drugmaker to lay off 100+ after Biogen acquisition

Reata Pharmaceuticals - a rare disease drugmaker recently acquired by Biogen - filed a WARN notice Oct. 9, alerting Texas officials of its plans to cut 113 positions. The layoffs will take effect Nov. 27.